Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Sun, Z.; Zhang, Y.
    Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculois drug pyrazinamide (1999), Antimicrob. Agents Chemother., 43, 537-542.
    View publication on PubMedView publication on EuropePMC

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.5.1.19 Pyrazinamide the natural resistance of Mycobacterium kansasii to pyrazinamide is due to a deficient pyrazinamidase activity of nicotinamidase Mycobacterium kansasii

Organism

EC Number Organism UniProt Comment Textmining
3.5.1.19 Mycobacterium kansasii
-
-
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.5.1.19 nicotinamide + H2O
-
Mycobacterium kansasii nicotinate + NH3
-
?
3.5.1.19 pyrazinamide + H2O the natural resistance of Mycobacterium kansasii to pyrazinamide is due to a deficient pyrazinamidase activity of nicotinamidase Mycobacterium kansasii pyrazinoic acid + NH3
-
?